Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	Hepatology 2012 (546 pages, free PDF) Hepatitis C 2012 (150 pages, free PDF)	Free Medical Books

Prostate Cancer

Free Subscription Articles published in Oncogene Retrieve available abstracts of 41 articles: HTML format Text format

Single Articles

May 2012
1. AHLQVIST K , Saamarthy K, Syed Khaja AS, Bjartell A, et al
   Expression of Id proteins is regulated by the Bcl-3 proto-oncogene in prostate cancer.
   Oncogene. 2012 May 14. doi: 10.1038/onc.2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   March 2012
2. PACCEZ JD , Vasques GJ, Correa RG, Vasconcellos JF, et al
   The receptor tyrosine kinase Axl is an essential regulator of prostate cancer proliferation and tumor growth and represents a new therapeutic target.
   Oncogene. 2012 Mar 12. doi: 10.1038/onc.2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. BOLL K , Reiche K, Kasack K, Morbt N, et al
   MiR-130a, miR-203 and miR-205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma.
   Oncogene. 2012 Mar 5. doi: 10.1038/onc.2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. ORR B , Riddick AC, Stewart GD, Anderson RA, et al
   Identification of stromally expressed molecules in the prostate by tag-profiling of cancer-associated fibroblasts, normal fibroblasts and fetal prostate.
   Oncogene. 2012;31:1130-42.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   February 2012
5. GULZAR ZG , McKenney JK, Brooks JD
   Increased expression of NuSAP in recurrent prostate cancer is mediated by E2F1.
   Oncogene. 2012 Feb 20. doi: 10.1038/onc.2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. BABBIO F , Pistore C, Curti L, Castiglioni I, et al
   The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression.
   Oncogene. 2012 Feb 13. doi: 10.1038/onc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. FORMOSA A , Lena AM, Markert EK, Cortelli S, et al
   DNA methylation silences miR-132 in prostate cancer.
   Oncogene. 2012 Feb 6. doi: 10.1038/onc.2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   January 2012
8. XU PZ , Chen ML, Jeon SM, Peng XD, et al
   The effect Akt2 deletion on tumor development in Pten(+/-) mice.
   Oncogene. 2012;31:518-26.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. LI Y , Hwang TH, Oseth LA, Hauge A, et al
   AR intragenic deletions linked to androgen receptor splice variant expression and activity in models of prostate cancer progression.
   Oncogene. 2012 Jan 23. doi: 10.1038/onc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. JALAVA SE , Urbanucci A, Latonen L, Waltering KK, et al
    Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer.
    Oncogene. 2012 Jan 23. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. MURA M , Swain RK, Zhuang X, Vorschmitt H, et al
    Identification and angiogenic role of the novel tumor endothelial marker CLEC14A.
    Oncogene. 2012;31:293-305.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. BYLES V , Zhu L, Lovaas JD, Chmilewski LK, et al
    SIRT1 induces EMT by cooperating with EMT transcription factors and enhances prostate cancer cell migration and metastasis.
    Oncogene. 2012 Jan 16. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2011
13. HUANG S , Gulzar ZG, Salari K, Lapointe J, et al
    Recurrent deletion of CHD1 in prostate cancer with relevance to cell invasiveness.
    Oncogene. 2011 Dec 19. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. THOBE MN , Gray JK, Gurusamy D, Paluch AM, et al
    The Ron receptor promotes prostate tumor growth in the TRAMP mouse model.
    Oncogene. 2011;30:4990-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. LIU W , Lindberg J, Sui G, Luo J, et al
    Identification of novel CHD1-associated collaborative alterations of genomic structure and functional assessment of CHD1 in prostate cancer.
    Oncogene. 2011 Dec 5. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
16. GHIAM AF , Cairns RA, Thoms J, Dal Pra A, et al
    IDH mutation status in prostate cancer.
    Oncogene. 2011 Nov 28. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles   
    
    
    
    
17. BJORKMAN M , Ostling P, Harma V, Virtanen J, et al
    Systematic knockdown of epigenetic enzymes identifies a novel histone demethylase PHF8 overexpressed in prostate cancer with an impact on cell proliferation, migration and invasion.
    Oncogene. 2011 Nov 28. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
18. WANG Y , Romigh T, He X, Tan MH, et al
    Differential regulation of PTEN expression by androgen receptor in prostate and breast cancers.
    Oncogene. 2011;30:4327-38.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. WANG LY , Kung HJ
    Male germ cell-associated kinase is overexpressed in prostate cancer cells and causes mitotic defects via deregulation of APC/C(CDH1).
    Oncogene. 2011 Oct 10. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
20. SHOLA DT , Wang H, Wahdan-Alaswad R, Danielpour D, et al
    Hic-5 controls BMP4 responses in prostate cancer cells through interacting with Smads 1, 5 and 8.
    Oncogene. 2011 Sep 26. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. HARMA V , Knuuttila M, Virtanen J, Mirtti T, et al
    Lysophosphatidic acid and sphingosine-1-phosphate promote morphogenesis and block invasion of prostate cancer cells in three-dimensional organotypic models.
    Oncogene. 2011 Sep 26. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. URBANUCCI A , Sahu B, Seppala J, Larjo A, et al
    Overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancer.
    Oncogene. 2011 Sep 12. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
23. WANG J , Anderson PD, Luo W, Gius D, et al
    Pim1 kinase is required to maintain tumorigenicity in MYC-expressing prostate cancer cells.
    Oncogene. 2011 Aug 22. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. UEMURA M , Zheng Q, Koh CM, Nelson WG, et al
    Overexpression of ribosomal RNA in prostate cancer is common but not linked to rDNA promoter hypomethylation.
    Oncogene. 2011 Aug 8. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
25. MARTENS-UZUNOVA ES , Jalava SE, Dits NF, van Leenders GJ, et al
    Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer.
    Oncogene. 2011 Jul 18. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. RAO S , Lyons LS, Fahrenholtz CD, Wu F, et al
    A novel nuclear role for the Vav3 nucleotide exchange factor in androgen receptor coactivation in prostate cancer.
    Oncogene. 2011 Jul 18. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
27. KIM J , Roh M, Doubinskaia I, Algarroba GN, et al
    A mouse model of heterogeneous, c-MYC-initiated prostate cancer with loss of Pten and p53.
    Oncogene. 2011 Jun 20. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. YU YP , Luo JH
    Phosphorylation and interaction of myopodin by integrin-link kinase lead to suppression of cell growth and motility in prostate cancer cells.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
29. ZHANG S , Wang X, Osunkoya AO, Iqbal S, et al
    EPLIN downregulation promotes epithelial-mesenchymal transition in prostate cancer cells and correlates with clinical lymph node metastasis.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. ROJAS A , Liu G, Coleman I, Nelson PS, et al
    IL-6 promotes prostate tumorigenesis and progression through autocrine cross-activation of IGF-IR.
    Oncogene. 2011;30:2345-55.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. MUSUMECI M , Coppola V, Addario A, Patrizii M, et al
    Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer.
    Oncogene. 2011.
    PubMed     Text format     Related articles   
    
    
    
    April 2011
32. YU X , Wang Y, DeGraff DJ, Wills ML, et al
    Wnt/beta-catenin activation promotes prostate tumor progression in a mouse model.
    Oncogene. 2011;30:1868-79.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. JETER CR , Liu B, Liu X, Chen X, et al
    NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
34. CHAE KS , Kang MJ, Lee JH, Ryu BK, et al
    Opposite functions of HIF-alpha isoforms in VEGF induction by TGF-beta1 under non-hypoxic conditions.
    Oncogene. 2011;30:1213-28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
35. FIELDING AB , Lim S, Montgomery K, Dobreva I, et al
    A critical role of integrin-linked kinase, ch-TOG and TACC3 in centrosome clustering in cancer cells.
    Oncogene. 2011;30:521-34.
    PubMed     Text format     Related articles   
    
    
    
    January 2011
36. PINEIRO R , Maffucci T, Falasca M
    The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation.
    Oncogene. 2011;30:142-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. LI X , Martinez-Ferrer M, Botta V, Uwamariya C, et al
    Epithelial Hic-5/ARA55 expression contributes to prostate tumorigenesis and castrate responsiveness.
    Oncogene. 2011;30:167-77.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
38. WANG ZA , Shen MM
    Revisiting the concept of cancer stem cells in prostate cancer.
    Oncogene. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
39. WANG B , Hasan MK, Alvarado E, Yuan H, et al
    NAMPT overexpression in prostate cancer and its contribution to tumor cell survival and stress response.
    Oncogene. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. TAKAYAMA K , Tsutsumi S, Katayama S, Okayama T, et al
    Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells.
    Oncogene. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
41. LIU Y , Karaca M, Zhang Z, Gioeli D, et al
    Dasatinib inhibits site-specific tyrosine phosphorylation of androgen receptor by Ack1 and Src kinases.
    Oncogene. 2010;29:3208-16.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: